Saturday 17 October 2026 Export KNSA’s income statement to Excel — free account

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare Drug Manufacturers Specialty & Generic

Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024. In the quarter to June 2026, revenue grew 55.4%, EPS grew 37.5% and free cash flow grew 66.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for five.

78.59 1.35 −1.69%

Follow KNSA

Alert me

Market cap: $6.2B
P/E: 73.4×
Fwd P/E: 38.7×
Dividend yield: —
F-score: 8/9
Altman Z: 10.35
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	8	8	8	8	+8 more TTM periods Free account
ROE Full definition →	14.04%	13.74%	11.73%	7.39%
ROA Full definition →	10.36%	10.26%	8.78%	5.67%
ROIC Full definition →	48.87%	42.34%	31.44%	13.01%
Return on Tangible Assets Full definition →	16.13%	16.62%	15.13%	10.16%
Average Days of Receivables Full definition →	10.20	11.24	8.40	31.58
Free Cash Flow per Share Full definition →	2.36	2.15	1.84	1.36
Free Cash Flow Full definition →	182.84	164.23	136.42	101.73
Capital Expenditures Full definition →	(2.13)	(1.63)	(1.57)	(1.13)
Other line items
Cash ROIC Full definition →	15.49%	15.29%	13.90%	11.46%
Accounts Receivable Turnover Full definition →	30.36	23.83	23.64	15.61
Accounts Payable Turnover Full definition →	8.01	6.11	38.20	10.31
Inventory Turnover Full definition →	1.44	1.69	1.91	2.13
Average Days of Payables Full definition →	52.91	110.50	9.53	30.08
Days of Inventory on Hand Full definition →	302.55	331.22	257.96	202.48
Tax Rate Full definition →	(0.29)	(0.31)	(0.34)	(0.26)
Research and Development Expense of Revenue Full definition →	15.12%	13.93%	14.29%	16.30%
Selling, General and Administrative Expense of Revenue Full definition →	27.46%	28.37%	28.97%	30.11%
Share Based Compensation of Revenue Full definition →	5.00%	5.21%	5.46%	5.86%
Operating CF/Net income Full definition →	2.29	2.27	2.34	2.86
Depreciation/Fixed assets Full definition →	0.70	0.84	0.80	0.90
Capex/Depreciation Full definition →	(1.19)	(0.97)	(1.01)	(0.76)
Revenue per Share Full definition →	10.84	9.85	9.13	8.00
Operating CF per Share Full definition →	2.38	2.17	1.86	1.38
Capex per Share Full definition →	(0.03)	(0.02)	(0.02)	(0.02)
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly